Xeris Pharmaceuticals Inc (XERS): Kapitalflussrechnung
Kennzahl in 1000 USD | TTM 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|
Umsatz | 335.414 | 291.845 | 203.070 | 163.914 | 110.248 | 49.590 | 2.722 | 2.722 | 2.465 | 1.556 | 1.075 |
Cashflow aus operativer Geschäftstätigkeit | 56.608 | 28.626 | -36.981 | -47.023 | -102.891 | -95.535 | -80.558 | -104.346 | -56.279 | -24.663 | -16.087 |
▸ Operative Cashflow Marge | 16,88% | 9,81% | -18,21% | -28,69% | -93,33% | -192,65% | -2.959,52% | -3.833,43% | -2.283,12% | -1.585,03% | -1.496,47% |
Investitionsausgaben (CapEx) | 1.230 | 696 | 868 | 2.263 | 524 | 1.085 | 377 | 1.107 | 1.510 | 700 | 35 |
Cashflow aus Investitionstätigkeit | -938 | -696 | 4.883 | -6.004 | 34.461 | 97.964 | -27.405 | -2.383 | -68.261 | -700 | -35 |
Cashflow aus Finanzierungstätigkeit | 6.690 | 11.389 | 36.168 | -1.613 | 127.473 | 27.247 | 126.064 | 80.530 | 128.211 | 35.139 | 3.904 |
Freier Cashflow | 55.378 | 27.930 | -37.849 | -49.286 | -103.415 | -96.620 | -80.935 | -105.453 | -57.789 | -25.363 | -16.122 |
▸ Freie Cashflow Marge | 16,51% | 9,57% | -18,64% | -30,07% | -93,8% | -194,84% | -2.973,37% | -3.874,1% | -2.344,38% | -1.630,01% | -1.499,72% |
Ausgeschüttete Dividenden | - | - | - | - | -147.050 | -25.089 | -95.643 | -60.684 | - | - | - |
Neuausgabe und Rückkäufe von Stammaktien | -19.226 | -10.876 | -3.734 | -1.009 | -468 | -534 | -63 | -4.465 | 98.325 | 35.139 | 3.919 |
Kennzahlen dieser Seite im Lexikon
Weitere Informationen findest du im Takani-Lexikon.